Haematological disorders, Guidance

Applied filters

COVID-19 Medicines Optimisation (1)
COVID-19 Vaccines (1)
- General information and guidance (1)
  - All vaccines: Answers to Questions (1)
Care Setting (2)
- Emergency medicine and urgent care (1)
- Trusts (2)
Events (1)
- Past Event (1)
- Webinars (1)
Guidance (92)
- Administering (3)
- Advanced therapy medicinal products (10)
- Cautions and contraindications (1)
- Dosing (4)
- Safety in Breastfeeding (51)
- Safety in Pregnancy (1)
- Stability in dosette boxes (40)
- Stability outside the fridge (23)
- Supply (1)
Interest areas (1)
- Medicines Safety (1)
Medicine (80)
- Agalsidase alfa (1)
- Albumin human (1)
- Alfacalcidol (1)
- Alglucosidase alfa (1)
- Aluminium hydroxide (1)
- Anagrelide (1)
- Apixaban (2)
- Ascorbic acid (1)
- Calcitriol (1)
- Calcium acetate (1)
- Calcium carbonate (1)
- Calcium polystyrene sulfonate (1)
- Carglumic acid (1)
- Carnitine (1)
- Celiprolol (1)
- Cinacalcet (1)
- Colecalciferol (1)
- Cyanocobalamin (2)
- Dabigatran etexilate (2)
- Dalteparin (2)
- Darbepoetin alfa (1)
- Deferasirox (1)
- Deferiprone (1)
- Eculizumab (1)
- Edoxaban (1)
- Eltrombopag (1)
- Enoxaparin (2)
- Epoetin alfa (1)
- Epoetin beta (1)
- Ergocalciferol (1)
- Factor VIII + von Willebrand factor (1)
- Ferric carboxymaltose (1)
- Ferrous fumarate (1)
- Ferrous gluconate (1)
- Ferrous sulfate (1)
- Fibrinogen + Thrombin (1)
- Filgrastim (1)
- Folic acid (1)
- Galsulfase (1)
- Haem arginate (1)
- Heparin (1)
- Hydroxocobalamin (3)
- Hydroxycarbamide (1)
- Idarucizumab (2)
- Idursulfase (1)
- Imiglucerase (1)
- Iron dextran (2)
- Iron isomaltoside 1000 (1)
- Lanthanum carbonate (1)
- Laronidase (1)
- Magnesium sulfate (1)
- Menadiol (1)
- Mercaptamine (1)
- Methoxy polyethylene glycol-epoetin beta (1)
- Miglustat (1)
- Nicotinamide (1)
- Nitisinone (1)
- Octocog alfa (1)
- Paricalcitol (1)
- Pegfilgrastim (1)
- Penicillamine (1)
- Phosphate (1)
- Phytomenadione (1)
- Potassium chloride (1)
- Pyridoxine (1)
- Riboflavin (1)
- Rivaroxaban (2)
- Romiplostim (1)
- Selenium (1)
- Sevelamer (1)
- Simvastatin + Ezetimibe (1)
- Sodium bicarbonate (1)
- Sodium chloride (1)
- Sodium phenylbutyrate (1)
- Thiamine (1)
- Tinzaparin (3)
- Trientine (1)
- Velaglucerase alfa (1)
- Warfarin (1)
- Zinc (1)
- Zinc acetate (1)
Planning (40)
- Biosimilars (2)
- New Medicines (27)
  - CCG commissioned new medicines (5)
  - NHS England commissioned new medicines (21)
  - Pre-registration new medicines (UK/EU) (3)
- Patent expiries (24)
Publications (1)
- Newsletters (1)
Specialty (92)
- Cancers (1)
- Cardiovascular system disorders (5)
- Ear, nose and throat disorders (2)
- Eyes and vision (3)
- Gastrointestinal disorders (2)
- Haematological disorders (92)
- Musculo-skeletal disorders (2)
- Nutritional and metabolic disorders (46)
- Obstetrics and gynaecology (1)
- Renal and urologic disorders (4)
- Respiratory disorders (1)
- Skin disorders (4)
- Surgery (1)
- Travel Medicine (1)

Comparative table of low molecular weight heparins and fondaparinux

29 July 2021This table has been compiled to aid product selection in the event of a shortage of a low molecular weight heparin.

RP-L102

2 April 2021dm+d: Unassigned

Using COVID-19 vaccines in patients with anticoagulation and bleeding disorders

7 January 2021Information on use of the vaccine in patients who are receiving anticoagulants or have a bleeding disorder is given below.

MUS Webinar – Update on NICE VTE Management Guidance & Safer Use of Anticoagulation in Primary Care

14 October 2020In this webinar, Frances and Alison outlined important issues from World Thrombosis week and key points from the NICE VTE guidelines (NG158, March 2020) and…

Oral vitamin B12 – what are the prescribing considerations and what formulations are available?

29 June 2020This Medicines Q&A outlines what oral vitamin B12 (cyanocobalamin) preparations are available and associated prescribing considerations. Hydroxocobalamin 1mg administered intramuscularly (IM) is the preferred method…